LS, MBH và DIF có sự tương hợp với nhau và đều có vai trò trong chẩn đoán các BDBNTM. Trong đó DIF rất quan trọng trong CĐXĐ các BDBNTM.
Trong nhóm pemphigoid:
LS, MBH và DIF có hiệu quả tương đương trong chẩn đoán. Cần kết hợp lâm sàng, DIF và mô bệnh học trong chẩn đoán.
Trong nhóm pemphigus:
MBH và DIF có hiệu quả chẩn đoán tương đương nhau và có ý nghĩa quan trọng trong hỗ trợ cho chẩn đoán lâm sàng.
DIF kết hợp với mô bệnh học giúp chẩn đoán chính xác 100% các trường hợp pemphigus.
CHƯƠNG 6: KIẾN NGHỊ
Qua quá trình thực hiện nghiên cứu và dựa vào kết quả nghiên cứu, chúng tôi đưa ra kiến nghị như sau:
Thực hiện xét nghiệm miễn dịch huỳnh quang trực tiếp thường quy đối với các trường hợp lâm sàng nghi ngờ BDBNTM để góp phần chẩn đoán xác định loại bệnh.
Cần thực hiện thêm các xét nghiệm miễn dịch huyết thanh để chẩn đoán phân biệt giữa BP và EBA.
TÀI LIỆU THAM KHẢO
Tiếng Việt
1. Trần Ngọc Ánh (2010), Nghiên cứu đặc điểm lâm sàng và tự kháng thể của một số bệnh da bóng nước tự miễn tại Bệnh Viện Da Liễu Thành phố Hồ Chí Minh, Luận văn Tiến sĩ Y học, Trường Đại Học Y Hà Nội.
Tiếng Anh
2. A Lally, A Chamberlain, Allen J, Dean D, Wojnarowska F (2007), “Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease”. Clin Exp Dermatol, 32 (5), pp. 493-8.
3. Alpsoy Erkan, Akman-Karakas Ayse, Uzun Soner (2015), “Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid”. Archives of Dermatological Research, 307 (4), pp. 291-298. 4. Anhalt G. J. (2004), “Paraneoplastic pemphigus”. J Investig Dermatol Symp Proc, 9
(1), pp. 29-33.
5. Antiga Emiliano, Maglie Roberto, Quintarelli Lavinia, Verdelli Alice, Bonciani Diletta, et al. (2019), “Dermatitis Herpetiformis: Novel Perspectives”. Frontiers in immunology, 10, pp. 1290-1290.
6. Aoki V, Sousa JX, Fukumori LM, Oliveira ZN (2010), “Direct and indirect immunofluorescence”. An Bras Dermatol, 85 (4), pp. 490-500.
7. Arbache ST, Nogueira TG, Delgado L, Aoki V (2014), “Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience”. Anais brasileiros de dermatologia, 89 (6), pp. 885-889.
8. Aringer M, Costenbader K, Daikh D, Brinks R, Johnson SR (2019), “2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus”. Arthritis Rheumatol, 71 (9), pp. 1400-1412.
9. Ashtari S, Pourhoseingholi MA, Rostami K (2019), “Prevalence of gluten-related disorders in Asia-Pacific region: a systematic review”. J Gastrointestin Liver Dis, 28 (1), pp. 95-105.
10. Aslanova M, Yarrarapu SNS, Zito PM (2021), "IgA Pemphigus", In: StatPearls, StatPearls Publishing
11. Bektas Meryem, Jolly Puneet, Rubenstein David S. (2010), “Apoptotic pathways in pemphigus”. Dermatology research and practice, 2010, pp. 456841-456841. 12. Bernard P., Vaillant L., Labeille B., Bedane C., Arbeille B., et al. (1995), “Incidence
and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group”. Arch Dermatol, 131 (1), pp. 48-52.
13. Bernett CN, Fong M, Rosario-Collazo JA (2021), "Linear IGA Dermatosis", In:
StatPearls, StatPearls Publishing
Copyright © 2021, StatPearls Publishing LLC., Treasure Island (FL).
14. Bertram F, Bröcker EB, Zillikens D, Schmidt E (2009), “Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany”. J Dtsch Dermatol Ges, 7 (5), pp. 434-40.
15. Blenkinsopp WK, Haffenden GP, Fry L, Leonard JN (1983), “Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid”. Am J Dermatopathol, 5 (6), pp. 547-54.
16. Bolotin D., Petronic-Rosic V. (2011), “Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation”. J Am Acad Dermatol, 64 (6), pp. 1017-24; quiz 1025-6.
17. Brenner Sarah, Goldberg Ilan (2011), “Drug-induced pemphigus”. Clinics in Dermatology, 29 (4), pp. 455-457.
18. Brian JH, Clay JC (2017), Diagnostic pathology: Nonneoplastic dermatology, 2nd Edition, Elsevier, Canada, pp.
19. Brick KE, Weaver CH, Lohse CM (2014), “Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009”. Journal of the American Academy of Dermatology, 71 (1), pp. 92-99.
20. Bruckner AL, Fitzpatrick JE, Hashimoto T (2005), “Atypical IgA/IgG pemphigus involving the skin, oral mucosa, and colon in a child: a novel variant of IgA pemphigus?”. Pediatr Dermatol, 22 (4), pp. 321-7.
21. Buch AC, Kumar H, Panicker N, Misal S, Sharma Y, et al. (2014), “A Cross- sectional Study of Direct Immunofluorescence in the Diagnosis of Immunobullous Dermatoses”. Indian J Dermatol, 59 (4), pp. 364-8.
22. Buijsrogge JJ, Diercks GF, Pas HH, Jonkman MF (2011), “The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy”. Br J Dermatol, 165 (1), pp. 92-8.
23. Burrows N. P., Bhogal B. S., Black M. M., Rustin M. H., Ishida-Yamamoto A., et al. (1993), “Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases”. Br J Dermatol, 128 (3), pp. 332-8. 24. Cahali JB, Kakuda EYS, Santi CG, Maruta CW (2002), “Nail manifestations in
pemphigus vulgaris”. Revista do Hospital das Clínicas, 57, pp. 229-234.
25. Calonje E, Thomas B, Alexander L, Billings S (2020), “McKee's pathology of the skin with clinical correlations”.
26. Camisa C., Sharma H. M. (1983), “Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature”. J Am Acad Dermatol, 9 (6), pp. 924-33.
27. Camisa C. (1988), “Vesiculobullous systemic lupus erythematosus. A report of four cases”. J Am Acad Dermatol, 18 (1 Pt 1), pp. 93-100.
28. Caproni M., Antiga E., Melani L., Fabbri P., The Italian Group for Cutaneous Immunopathology (2009), “Guidelines for the diagnosis and treatment of dermatitis herpetiformis”. Journal of the European Academy of Dermatology and Venereology, 23 (6), pp. 633-638.
29. Carayannopoulos L, Hexham JM, Capra JD (1996), “Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1”. J Exp Med, 183 (4), pp. 1579-86.
30. Carey B., Setterfield J. (2019), “Mucous membrane pemphigoid and oral blistering diseases”. Clinical and Experimental Dermatology, 44 (7), pp. 732-739.
31. Castro R. M., Roscoe J. T., Sampaio S. A. (1983), “Brazilian pemphigus foliaceus”.
Clin Dermatol, 1 (2), pp. 22-41.
32. Chams-Davatchi C, Valikhani M, Daneshpazhooh M (2005), “Pemphigus: analysis of 1209 cases”. Int J Dermatol, 44 (6), pp. 470-6.
33. Chanprapaph K, Sawatwarakul S, Vachiramon V (2017), “A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients”. Lupus, 26 (12), pp. 1278-1284.
34. Chaudhari S, Mobini N (2015), “Linear IgA Bullous Dermatosis: A Rare Clinicopathologic Entity with an Unusual Presentation”. The Journal of clinical and aesthetic dermatology, 8 (10), pp. 43-46.
35. Chhabra S, Minz RW, Saikia B (2012), “Immunofluorescence in dermatology”.
36. Chiu HY, Chang CJ, Lin YJ, Tsai TF (2020), “National trends in incidence, mortality, hospitalizations, and expenditures for pemphigus in Taiwan”. J Dermatol Sci, 99 (3), pp. 203-208.
37. Clapé A, Muller C, Gatouillat G (2018), “Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti- BP230 Autoantibody”. Frontiers in immunology, 9, pp. 479-479.
38. Contestable J. J., Edhegard K. D., Meyerle J. H. (2014), “Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment”. Am J Clin Dermatol, 15 (6), pp. 517-24.
39. Contestable JJ, Edhegard KD, Meyerle JH (2014), “Bullous Systemic Lupus Erythematosus: A Review and Update to Diagnosis and Treatment”. American Journal of Clinical Dermatology, 15 (6), pp. 517-524.
40. Cozzani E, Drosera M, Rebora A (2004), “Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid”. Acta Derm Venereol, 84 (5), pp. 381-4.
41. DE Elder, R Elenitsas, BL Johnson, GF Murphy (2005), "Histology of the skin", In: Murphy GF., Editor Lever’s Histopathology of the Skin. 9th ed., PA: Lippincott Williams & Wilkins, Philadelphia.
42. de Risi-Pugliese T., Cohen Aubart F., Haroche J., Moguelet P., Grootenboer-Mignot S., et al. (2018), “Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases”. Semin Arthritis Rheum, 48 (1), pp. 83-89.
43. Diaz L. A., Sampaio S. A., Rivitti E. A., Martins C. R., Cunha P. R., et al. (1989), “Endemic pemphigus foliaceus (fogo selvagem). I. Clinical features and immunopathology”. J Am Acad Dermatol, 20 (4), pp. 657-69.
44. Diercks Gilles F. H., Pas Hendri H. (2016), "Direct Immunofluorescence Microscopy", In: Marcel F. Jonkman, Editor Autoimmune Bullous Diseases: Text and Review, Springer International Publishing, Cham, pp. 39-46.
45. Eaton D. P., Diaz L. A., Hans-Filho G., Santos V. D., Aoki V., et al. (1998), “Comparison of black fly species (Diptera: Simuliidae) on an Amerindian reservation with a high prevalence of fogo selvagem to neighboring disease-free sites in the State of Mato Grosso do Sul, Brazil. The Cooperative Group on Fogo Selvagem Research”. J Med Entomol, 35 (2), pp. 120-31.
46. Egan CA, Zone JJ (1999), “Linear IgA bullous dermatosis”. Int J Dermatol, 38 (11), pp. 818-27.
47. Elston Dirk M., Stratman Erik J., Miller Stanley J. (2016), “Skin biopsy: Biopsy issues in specific diseases”. Journal of the American Academy of Dermatology, 74 (1), pp. 1-16.
48. Elston DM, Stratman EJ, Miller SJ (2016), “Skin biopsy: Biopsy issues in specific diseases”. Journal of the American Academy of Dermatology, 74 (1), pp. 1-16. 49. Engineer L, Norton LA, Ahmed AR (2000), “Nail involvement in pemphigus
vulgaris”. Journal of the American Academy of Dermatology, 43 (3), pp. 529-535. 50. Erdag G, Qureshi HS, Greer KE “Immunoglobulin A pemphigus involving the perianal skin and oral mucosa: an unusual presentation”. Cutis, 80(3), pp. 218-20. 51. Esmaili N, Chams-Davatchi C, Valikhani M, Daneshpazhooh M (2007), “Pemphigus vulgaris in Iran: a clinical study of 140 cases”. International Journal of Dermatology, 46 (11), pp. 1166-1170.
52. Fernandes KA, Galvis KH, Gomes AC, Vargas TJ (2016), “Linear IgA and IgG bullous dermatosis”. An Bras Dermatol, 91 (5 suppl 1), pp. 32-34.
53. Fisler RE, Saeb M, Liang MG, Howard RM, McKee PH (2003), “Childhood bullous pemphigoid: a clinicopathologic study and review of the literature”. Am J Dermatopathol, 25 (3), pp. 183-9.
54. Fleming T. E., Korman N. J. (2000), “Cicatricial pemphigoid”. J Am Acad Dermatol, 43 (4), pp. 571-91; quiz 591-4.
55. Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP (2012), “A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity?”. J Am Acad Dermatol, 66 (6), pp. 988-94.
56. Fuertes de Vega I, Iranzo-Fernández P, Mascaró-Galy JM (2014), “Bullous pemphigoid: clinical practice guidelines”. Actas Dermosifiliogr, 105 (4), pp. 328- 46.
57. Gammon W. R., Briggaman R. A. (1993), “Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder”. J Invest Dermatol, 100 (1), pp. 28s-34s.
58. Gammon W. R., Briggaman R. A., Inman A. O., 3rd, Merritt C. C., Wheeler C. E., Jr. (2003), “Evidence supporting a role for immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus”. J Invest Dermatol, 81 (4), pp. 320-5.
59. Gammon W. R., Briggaman R. A. (2010), “Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen”. Dermatol Clin, 11 (3), pp. 535-47.
60. Gammon W. R., Briggaman R. A. (2011), “Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder”. J Invest Dermatol, 100 (1), pp. 28s-34s.
61. Gardner KM, Crawford RI (2018), “Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence”. J Cutan Med Surg, 22 (1), pp. 22-24.
62. Genovese G, Venegoni L, Fanoni D (2019), “Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients”.
Orphanet Journal of Rare Diseases, 14 (1), pp. 115.
63. Genovese Giovanni, Di Zenzo Giovanni, Cozzani Emanuele, Berti Emilio, Cugno Massimo, et al. (2019), “New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update”. Frontiers in Immunology, 10, pp. 1506.
64. Giurdanella F, Diercks GFH, Jonkman MF, Pas HH (2016), “Laboratory diagnosis of pemphigus: direct immunofluorescence remains the gold standard”. British Journal of Dermatology, 175 (1), pp. 185-186.
65. Grabell Daniel A., Matthews Loderick A., Yancey Kim B., Chong Benjamin F. (2015), “Detection of Type VII Collagen Autoantibodies Before the Onset of Bullous Systemic Lupus Erythematosus”. JAMA dermatology, 151 (5), pp. 539- 543.
66. Grando S. A., Bystryn J. C., Chernyavsky A. I., Frusic-Zlotkin M., Gniadecki R., et al. (2009), “Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis”. Exp Dermatol, 18 (9), pp. 764-70.
67. Griffiths Christopher E. M., Barker Jonathan, Bleiker Tanya, Chalmers Robert, Creamer Daniel (2016), Rook’s Textbook of Dermatopathology, Willey Blackwell, Oxford, pp.
68. Hallaji Z., Mortazavi H., Ashtari S., Nikoo A., Abdollahi M., et al. (2016), “Pemphigoid gestationis: Clinical and histologic features of twenty-three patients”. International journal of women's dermatology, 3 (2), pp. 86-90.
69. Hallel-Halevy D., Nadelman C., Chen M., Woodley D. T. (2001), “Epidermolysis bullosa acquisita: update and review”. Clin Dermatol, 19 (6), pp. 712-8.
70. Hammers Christoph M., Stanley John R. (2016), “Mechanisms of Disease: Pemphigus and Bullous Pemphigoid”. Annual review of pathology, 11, pp. 175- 197.
71. Hanan R, Aniek L, Diercks FH (2019), “Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm”.
American Journal of Clinical Dermatology, 20 (6), pp. 847-861.
72. Hans-Filho G., Aoki V., Rivitti E., Eaton D. P., Lin M. S., et al. (1999), “Endemic pemphigus foliaceus (fogo selvagem)--1998. The Cooperative Group on Fogo Selvagem Research”. Clin Dermatol, 17 (2), pp. 225-35; discussion 105-6. 73. Hashimoto T, Tsuruta D, Koga H, Ishii N (2016), “Summary of results of
serological tests and diagnoses for 4774 cases of various autoimmune bullous diseases consulted to Kurume University”. Br J Dermatol, 175 (5), pp. 953-965. 74. Hashimoto T, Teye K, Hashimoto K, Wozniak K, Ueo D, et al. (2018), “Clinical and
Immunological Study of 30 Cases With Both IgG and IgA Anti-Keratinocyte Cell Surface Autoantibodies Toward the Definition of Intercellular IgG/IgA Dermatosis”. Front Immunol, 9, pp. 994.
75. Hashimoto T., Teye K., Ishii N. (2017), “Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University”. British Journal of Dermatology, 176 (1), pp. 168-175.
76. Hashimoto Takashi, Ishii Norito, Ohata Chika, Furumura Minao (2012), “Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease”. The Journal of Pathology, 228 (1), pp. 1-7.
77. Hodge BD, Roach J, Reserva JL, Brodell RT (2018), “The spectrum of histopathologic findings in pemphigoid: Avoiding diagnostic pitfalls”. Journal of Cutaneous Pathology, 45 (11), pp. 831-838.
78. Hussein MR, Ali FM, AE Omar (2007), “Immunohistological analysis of immune cells in blistering skin lesions”. Journal of clinical pathology, 60 (1), pp. 62-71. 79. Ishiko A., Matsunaga Y., Masunaga T., Aiso S., Nishikawa T., et al. (2003),
“Immunomolecular mapping of adherens junction and desmosomal components in normal human epidermis”. Exp Dermatol, 12 (6), pp. 747-54.
80. Joly P, Richard C, Gilbert D (2000), “Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus”. J Am Acad Dermatol, 43 (4), pp. 619-26.
81. Jonkman Marcel F., Diercks Gilles F. H. (2016), "How to Take a Biopsy", In: Marcel F. Jonkman, Editor Autoimmune Bullous Diseases, Springer, Switzerland.
82. Jonkman MF (2016), Autoimmune Bullous Diseases, Text and Review, Springer, Switzerland, pp.
83. Jowkar F, Sadati MS, Tavana S, Agah MA (2014), “Epidemiology of autoimmune bullous diseases and therapeutic modalities during a 10 year period in Iran”. Acta Dermatovenerol Croat, 22 (4), pp. 246-9.
84. Jung M, Kippes W, Messer G (1999), “Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence”. J Am Acad Dermatol, 41 (2 Pt 1), pp. 266-8.
85. Kalaaji Amer N., Nicolas Marie Eleanore O. (2006), Mayo Clinic Atlas of Immunofluorescence in Dermatology, Mayo Clinic Scientific Group, Minnesota, USA, pp.
86. Kambi DP, Santosh CS, Sugnua B (2013), “Direct immunofluorescence study in autoimmune bullous disorders of skin”. International Journal of Biomedical and Advance Research, 4, pp. 610-618.
87. Kang Sewon, Amagai Masayuki, Bruckner Anna L., Enk Alexander H., Margolis David J., et al. (2019), Fitzpatrick’s Dermatology, 9th Edition, McGraw-Hill Education, New York, pp.
88. Kanik Andrew, Li Min, Urmacher Carlos D. (2012), "Normal Skin", In: Stacey E. Mills, Editor Histology for Pathologists, 4th Edition, Wolters Kluwer, 4th. Philadelphia, pp. 3-27.
89. Kanwar AJ, Sandhu K, Handa S (2004), “Chronic bullous dermatosis of childhood in north India”. Pediatr Dermatol, 21 (5), pp. 610-2.
90. Kappius RH, Ufkes NA, Thiers BH (2021), "Paraneoplastic Pemphigus", In:
StatPearls, StatPearls Publishing
Copyright © 2021, StatPearls Publishing LLC., Treasure Island (FL).
91. Kenani N, Mebazaa A, Denguezli M (2009), “Childhood linear IgA bullous dermatosis in Tunisia”. Pediatr Dermatol, 26 (1), pp. 28-33.
92. Kettler A. H., Bean S. F., Duffy J. O., Gammon W. R. (1988), “Systemic lupus erythematosus presenting as a bullous eruption in a child”. Arch Dermatol, 124 (7), pp. 1083-7.
93. Kharfi M, Khaled A, Karaa A (2010), “Linear IgA bullous dermatosis: the more frequent bullous dermatosis of children”. Dermatol Online J, 16 (1), pp. 2. 94. Kim Jong Hoon, Kim Soo-Chan (2019), “Paraneoplastic Pemphigus: Paraneoplastic
Autoimmune Disease of the Skin and Mucosa”. Frontiers in immunology, 10, pp. 1259-1259.
95. Kridin K, Sagi SZ, Bergman R (2017), “Mortality and Cause of Death in Patients with Pemphigus”. Acta Derm Venereol, 97 (5), pp. 607-611.
96. Kridin K (2018), “Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations”. Immunologic Research, 66 (1), pp. 6-17.